Correlation Between NYSE Composite and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Transcode Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Transcode Therapeutics.
Diversification Opportunities for NYSE Composite and Transcode Therapeutics
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NYSE and Transcode is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Transcode Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.12 times more return on investment than Transcode Therapeutics. However, NYSE Composite is 8.36 times less risky than Transcode Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.36 per unit of risk. If you would invest 1,954,967 in NYSE Composite on August 27, 2024 and sell it today you would earn a total of 57,378 from holding NYSE Composite or generate 2.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Transcode Therapeutics
Performance |
| Timeline |
NYSE Composite and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Transcode Therapeutics
Pair trading matchups for Transcode Therapeutics
Pair Trading with NYSE Composite and Transcode Therapeutics
The main advantage of trading using opposite NYSE Composite and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| NYSE Composite vs. Grocery Outlet Holding | NYSE Composite vs. Tencent Music Entertainment | NYSE Composite vs. SunLink Health Systems | NYSE Composite vs. Getty Realty |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |